Single-Dose Anticoagulant Promising in Knee Replacement

]]>(MedPage Today) -- A monoclonal antibody against coagulation factor XI is being studied to prevent venous thromboembolism (VTE) after knee arthroplasty, with a phase II study suggesting that a single, modest dose could be on par with standard therapy...